Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective

Articolo

Data di Pubblicazione:

2020

Citazione:

Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective / Allen, Pb; Bonovas, S; Danese, S; Peyrin-Biroulet, L. - In: EXPERT OPINION ON BIOLOGICAL THERAPY. - ISSN 1471-2598. - 20:2(2020), pp. 151-161. [10.1080/14712598.2020.1702020]

Tipologia CRIS:

1.1 Articolo in rivista

Elenco autori:

Allen, Pb; Bonovas, S; Danese, S; Peyrin-Biroulet, L

Autori di Ateneo:

DANESE SILVIO

Link alla scheda completa:

https://iris.unisr.it/handle/20.500.11768/119943

Pubblicato in:

EXPERT OPINION ON BIOLOGICAL THERAPY

Journal